Home/Filings/4/0001654954-19-014155
4//SEC Filing

Hendricks Diane 4

Accession 0001654954-19-014155

CIK 0001645469other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 7:10 PM ET

Size

6.3 KB

Accession

0001654954-19-014155

Insider Transaction Report

Form 4
Period: 2019-12-18
Transactions
  • Purchase

    Common stock

    2019-12-18$8.00/sh+468,750$3,750,000468,750 total(indirect: See Footnote 1)
Holdings
  • Common stock

    (indirect: See Footnote 2)
    3,055,394.12
Footnotes (2)
  • [F1]This is based upon the 468,750 shares of Monopar Common Stock that DMH Business LLC directly owns. As a manager of DMH Business LLC, Ms. Hendricks may be deemed to share voting and dispositive power over these 468,750 shares. Ms. Hendricks disclaims beneficial ownership of the 468,750 shares held by DMH Business LLC, except to the extent of her pecuniary interest therein.
  • [F2]Gem Pharmaceuticals LLC ("Gem"), an Alabama limited liability company, has voting and investment power over 3,055,394.12 of the shares of common stock held by TacticGem LLC. Diane Hendricks is a manager of Gem and along with other managers collectively have voting control over the securities described herein. Pharma Investments LLC ("Pharma") owns a controlling share of Gem and Diane Hendricks owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein.

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001727478

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:10 PM ET
Size
6.3 KB